mdl-100907 and Heroin-Dependence

mdl-100907 has been researched along with Heroin-Dependence* in 1 studies

Other Studies

1 other study(ies) available for mdl-100907 and Heroin-Dependence

Article	Year
A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents. The European journal of neuroscience, 2017, Volume: 45, Issue:11 Despite several studies suggesting the therapeutic use of 5-hydroxytryptamine receptors type 2A (5-HT Topics: Animals; Brain-Derived Neurotrophic Factor; Hallucinogens; Heroin Dependence; Male; Mice; Mice, Inbred C57BL; N,N-Dimethyltryptamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Tryptamines; Ventral Tegmental Area	2017

Article

Year

A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents.

The European journal of neuroscience, 2017, Volume: 45, Issue:11

Despite several studies suggesting the therapeutic use of 5-hydroxytryptamine receptors type 2A (5-HT

Topics: Animals; Brain-Derived Neurotrophic Factor; Hallucinogens; Heroin Dependence; Male; Mice; Mice, Inbred C57BL; N,N-Dimethyltryptamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome; Tryptamines; Ventral Tegmental Area

2017